171 related articles for article (PubMed ID: 9296213)
21. Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management.
Hortobagyi GN; Buzdar AU
Cancer Invest; 1998; 16(6):385-90. PubMed ID: 9679529
[No Abstract] [Full Text] [Related]
22. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
23. Hormonal therapy in early and advanced breast cancer.
Buzdar AU
Breast J; 2004; 10 Suppl 1():S19-21. PubMed ID: 14984485
[TBL] [Abstract][Full Text] [Related]
24. Aromatase inhibitors: a dose-response effect?
Smith IE
Endocr Relat Cancer; 1999 Jun; 6(2):245-9. PubMed ID: 10731116
[No Abstract] [Full Text] [Related]
25. Aromatase inhibitors continue their ATAC on tamoxifen.
Nicholls H
Trends Mol Med; 2002; 8(4 Suppl):S12-3. PubMed ID: 11927281
[No Abstract] [Full Text] [Related]
26. An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole.
Tobias JS; Howell A
Eur J Cancer; 2004 Aug; 40(12):1913. PubMed ID: 15288295
[No Abstract] [Full Text] [Related]
27. New aromatase inhibitors in the treatment of advanced breast cancer.
Crucitta E; Lorusso V; Attolico M; Sambiasi D; Mazzei A; De Lena M
Int J Oncol; 2000 Nov; 17(5):1037-41. PubMed ID: 11029510
[TBL] [Abstract][Full Text] [Related]
28. Steroidal aromatase inhibitors in elderly patients.
Bajetta E; Zilembo N; Bichisao E; Pozzi P; Toffolatti L
Crit Rev Oncol Hematol; 2000 Feb; 33(2):137-42. PubMed ID: 10737375
[TBL] [Abstract][Full Text] [Related]
29. Extended adjuvant therapy for breast cancer--how much is enough?
Prowell TM; Stearns V
J Natl Cancer Inst; 2007 Dec; 99(24):1825-7. PubMed ID: 18073372
[No Abstract] [Full Text] [Related]
30. A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
Rose C
Am J Clin Oncol; 2003 Aug; 26(4):S9-16. PubMed ID: 12902872
[TBL] [Abstract][Full Text] [Related]
31. An overview of the use of non-steroidal aromatase inhibitors in the treatment of breast cancer.
Buzdar A
Eur J Cancer; 2000 Sep; 36 Suppl 4():S82-4. PubMed ID: 11056331
[TBL] [Abstract][Full Text] [Related]
32. Aromatase inhibitors in breast cancer: an update.
Lake DE; Hudis C
Cancer Control; 2002; 9(6):490-8. PubMed ID: 12514567
[TBL] [Abstract][Full Text] [Related]
33. Letrozole: advancing hormone therapy in breast cancer.
Lee RJ; Armstrong AC; Wardley AM
Womens Health (Lond); 2012 Nov; 8(6):611-8. PubMed ID: 23181527
[TBL] [Abstract][Full Text] [Related]
34. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
[TBL] [Abstract][Full Text] [Related]
35. The control and biological importance of intratumoural aromatase in breast cancer.
Dowsett M; Lee K; Macaulay VM; Detre S; Rowlands M; Grimshaw R
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):145-50. PubMed ID: 8603035
[TBL] [Abstract][Full Text] [Related]
36. A summary of second-line randomized studies of aromatase inhibitors.
Buzdar AU
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):109-14. PubMed ID: 11850214
[TBL] [Abstract][Full Text] [Related]
37. A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer.
Kleeberg UR; Dowsett M; Carrion RP; Dodwell DJ; Vorobiof DA; Aparicio LA; Robertson JF
Oncology; 1997; 54 Suppl 2():19-22. PubMed ID: 9394856
[TBL] [Abstract][Full Text] [Related]
38. An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.
Rose C; Vtoraya O; Pluzanska A; Davidson N; Gershanovich M; Thomas R; Johnson S; Caicedo JJ; Gervasio H; Manikhas G; Ben Ayed F; Burdette-Radoux S; Chaudri-Ross HA; Lang R
Eur J Cancer; 2003 Nov; 39(16):2318-27. PubMed ID: 14556923
[TBL] [Abstract][Full Text] [Related]
39. Aromatase inhibitors and breast cancer: time for a change?
Fentiman IS
Int J Clin Pract; 2004 Dec; 58(12):1152-8. PubMed ID: 15646413
[TBL] [Abstract][Full Text] [Related]
40. The adjuvant endocrine treatment revolution: focus on anastrozole.
Jakesz R
Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):301-12. PubMed ID: 16866615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
